HSBC Downgrades Eli Lilly, Cuts PT to $850, Flags Obesity Market Risks [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus HSBC analysts have turned more cautious on Eli Lilly ( NYSE:LLY ), arguing that expectations tied to the company's weight-loss drug opportunity could be running ahead of what the market may ultimately deliver. In a note led by Rajesh Kumar, the bank downgraded the stock to reduce from hold and lowered its price target to $850, now the lowest target on Wall Street. The move stands out given how rarely the drugmaker has carried sell-equivalent ratings over the past decade, underscoring a shift in sentiment after a prolonged rally. Warning! GuruFocus has detected 2 Warning Sign with NVO. Is NVO fairly valued? Test your thesis with our free DCF calculator. The analysts' concern centers on how competition could reshape the obesity drug landscape, particularly as Novo Nordisk ( NYSE:NVO ) works to defend its position, potentially putting pressure on pricing. HSBC's analysis suggests that pricing, rather than product features, may be the domi
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure [Yahoo! Finance]Yahoo! Finance
- Alzheimer's Association Announces New Brain Health Roundtable [Yahoo! Finance]Yahoo! Finance
- Why Eli Lilly Stock Just Dropped [Yahoo! Finance]Yahoo! Finance
- Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216 [Yahoo! Finance]Yahoo! Finance
- ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer's Precision Medicine Worldwide [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/17/26 - Form 4
- 3/17/26 - Form 4
- 3/17/26 - Form 4
- LLY's page on the SEC website